The group’s principle activities include developing and commercializing sample preparation technologies that enable clinical utilization of the immense resolving power of mass spectrometry. The group’s services include tissue-imaging by-the-slice, protein biomarker discovery with imaging mass spectrometry, and small molecule localization in early drug development with imaging mass spectrometry. The group operates from United States.
